Contrast Media

One Stop Shop MRI Contrast Agent. A Gadolinium – BOPTA molecule having Double relaxivity and Dual route of elimination.      

MultiHance Contrast Media, the highest relaxivity gadolinium-based contrast agent (GBCA) approved for MRI of the CNS and whole body, delivers significantly better contrast enhancement in diagnostic imaging of CNS lesions and other pathologies compared to other MRI agents available in the market.

Multihance has an additional feature of being the only MRI contrast available in the market, which is excreted through the Hepatobiliary route in addition to the renal route.


Features:

 

• Double relaxivity agent 
• Additional Hepatobiliary excretion in addition to renal excretion. 

Benefits:

• Due to its double relaxitivity Multihance gives more information at same dose, or similar information at lesser dose compared to competitor brands.
• Due to its hepatobiliary excretory capability, Delayed Liver Imaging (up to three hours after administration) is possible, for studying liver pathologies.
• No contraindication for use in high risk patient groups with reduced renal function

Specification:

• Multihance contains Gadobenate Dimeglumine (Gd Bopta)
• Multihance is US FDA Approved. 

One that stood the test of timeIopamiro (Iopamidol) is a non ionic water soluble contrast used for diagnostic radiological and cardiology indications.

Iopamiro is an xray contrast medium of the new generation of non ionic compounds and discovered by Bracco in 1981 which are watersoluble because the molecular structure incorporates hydrophilic groups. This new class of contrast media (NonIonics) differs significantly from earlier compounds (Ionics) all of which are soluble only when the radiopaque molecule is ionized by forming a salt with sodium and  or meglumine. 

While Ionics are remarkably well tolerated their aqueous solutions show an inherently high osmolality and this is responsible for a number of side effects that may occur after administration. The discovery of non ionic contrast agents has afforded along with a sizable reduction of general toxicity a considerable improvement in local and tissue tolerability even for the more delicate structures of the human body such as vascular endothelia and the central nervous system


Features:

 

Iopamiro is the first water soluble non ionic discovered in the world, and safe (380 million doses sold worldwide), extensively documented (over 2000 published papers), and approved in wide range of indications including Pediatric populations. 


Benefits:
Iopamiro is a contrast agent for diagnosis of radiological procedures in Radiology, CT, Urography, HSG, DSA and interventional Cath Lab procedures in cardiac angiography, PTCA, etc. 


Specification:

 

• Iopamiro contains Iopamidol
• Iopamidol is US FDA Approved.

Go higher see better A water soluble non ionic iodinated contrast inj. indicated for CT Radiological and Cath Lab procedures.

Iomeron Injection Xray contrast agent helps optimize images obtained with sophisticated multidetector computed tomography (MDCT) technology especially for neurological brain liver cardiac and vascular scanning.

Iomeron is a triiodinated nonionic contrast media with the most innovative profile and highest concentration of iodine available in the market (400 mglmL). The use of very high concentration of iodinated contrast agents such as Iomeron400 helps radiologists obtain the clearest most diagnostically useful images to more accurately identify pathology and evaluate treatment.


Features:

• Iomeron at the same concentration as competitor brands have the lowest osmolality and viscosity. 
• Iomeron is only non ionic with absence of Calcium di-Sodium Edetate, still stable for five years. 

Benefits:

• In the new generation MDCT, Iomeron 400mg the highest concentration contrast are specially suitable for all angiography procedures like Coronary CT, Triple phase liver study, peripheral CT, pulmonary angio,  perfusion studies etc. 
• Iomeron has shown optimal renal tolerability and its high concentration does not lead to higher incidence of adverse events when compared to lower concentration. 
• Iomeron allows same imaging quality at lower radiation dose.